Suppr超能文献

苦味感知与苦味受体变体的临床关联以及个性化医疗的潜力

Clinical Associations of Bitter Taste Perception and Bitter Taste Receptor Variants and the Potential for Personalized Healthcare.

作者信息

Mao Ziwen, Cheng Weyland, Li Zhenwei, Yao Manye, Sun Keming

机构信息

Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, Henan, People's Republic of China.

Department of Orthopaedic Surgery, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, Henan, People's Republic of China.

出版信息

Pharmgenomics Pers Med. 2023 Feb 12;16:121-132. doi: 10.2147/PGPM.S390201. eCollection 2023.

Abstract

Bitter taste receptors (T2Rs) consist of 25 functional receptors that can be found in various types of cells throughout the human body with responses ranging from detecting bitter taste to suppressing pathogen-induced inflammation upon activation. Numerous studies have observed clinical associations with genetic or phenotypic variants in bitter taste receptors, most notably that of the receptor isoform T2R38. With genetic variants playing a role in the response of the body to bacterial quorum-sensing molecules, bacterial metabolites, medicinal agonists and nutrients, we examine how T2R polymorphisms, expression levels and bitter taste perception can lead to varying clinical associations. From these genetic and phenotypic differences, healthcare management can potentially be individualized through appropriately administering drugs with bitter masking to increase compliance; optimizing nutritional strategies and diets; avoiding the use of T2R agonists if this pathway is already activated from bacterial infections; adjusting drug regimens based on differing prognoses; or adjusting drug regimens based on T2R expression levels in the target cell type and bodily region.

摘要

苦味受体(T2Rs)由25种功能性受体组成,这些受体存在于人体各种类型的细胞中,其反应范围从检测苦味到激活后抑制病原体诱导的炎症。大量研究观察到苦味受体的基因或表型变异与临床的关联,最显著的是受体亚型T2R38。由于基因变异在人体对细菌群体感应分子、细菌代谢产物、药用激动剂和营养物质的反应中起作用,我们研究了T2R多态性、表达水平和苦味感知如何导致不同的临床关联。基于这些基因和表型差异,医疗管理有可能通过以下方式实现个体化:适当给予具有苦味掩盖作用的药物以提高依从性;优化营养策略和饮食;如果该途径已因细菌感染而激活,则避免使用T2R激动剂;根据不同的预后调整药物方案;或根据靶细胞类型和身体区域的T2R表达水平调整药物方案。

相似文献

4
Bitter Taste Receptor as a Therapeutic Target in Orthopaedic Disorders.苦味受体作为骨科疾病的治疗靶点。
Drug Des Devel Ther. 2021 Feb 26;15:895-903. doi: 10.2147/DDDT.S289614. eCollection 2021.
5
Bitter taste receptors: Extraoral roles in pathophysiology.苦味受体:病理生理学中的口外作用。
Int J Biochem Cell Biol. 2016 Aug;77(Pt B):197-204. doi: 10.1016/j.biocel.2016.03.011. Epub 2016 Mar 23.
9
The pharmacology of bitter taste receptors and their role in human airways.苦味受体的药理学及其在人体气道中的作用。
Pharmacol Ther. 2015 Nov;155:11-21. doi: 10.1016/j.pharmthera.2015.08.001. Epub 2015 Aug 10.

本文引用的文献

1
Role of the Gut Microbiome and Bile Acids.肠道微生物群和胆汁酸的作用。
Dtsch Arztebl Int. 2022 Sep 5;119(35-36):609. doi: 10.3238/arztebl.m2022.0177.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验